DPP4 and chronic myelogenous leukemia, BCR-ABL1 positive: To selectively target CML LSCs/progenitor cells that express CD26 and to spare normal HSCs/progenitor cells, we designed a venetoclax-loaded immunoliposome (IL-VX).